CClinicalTrials.gg
RecruitingNCT05901402Updated Feb 6, 2024

Application of Aerobic and Resistance Exercise in Blood Glucose Control in Pregnant Women With GDM

An interventional study of aerobic and resistance exercise in Aerobic and Resistance Exercise, sponsored by Second Affiliated Hospital of Wenzhou Medical University. Recruiting at 1 site in China. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by Second Affiliated Hospital of Wenzhou Medical University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Objective:The aim of this study was to explore the rationality and clinical value of aerobic exercise during pregnancy in blood glucose control of pregnant women with GDM, and to provide theoretical basis for more appropriate clinical exercise management.

Method:The subjects of gestational diabetes in the hospital from March 2023 to May 2024 were studied. The exercise exercise with daily responsible nurses was based on resistance exercise, mainly with upper limb muscle exercise, supplemented by lower limb muscle exercise and aerobic exercise. Fasting blood glucose, 2 hours postprandial blood glucose and HbA1c in pregnant women with GDM were monitored.

02

Conditions studied

  • Aerobic and Resistance Exercise

Keywords

  • the pregnant women with GDM
  • blood glucose
03

In context

Lead sponsor

Second Affiliated Hospital of Wenzhou Medical University is the lead sponsor of 133 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pregnant women with GDM without contraindications.
  • Pregnant women with GDM who volunteered to participate in the project.
  • Pregnant women give informed consent.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women give up voluntarily.
  • Hypoglycemia: In the presence of dizziness and other uncomfortable symptoms, people should stop exercising immediately, monitor blood sugar, and always prepare candy.
  • Abdominal pain, vaginal bleeding and other symptoms of contraction should stop exercising immediately and seek medical attention in time.
  • Fall: It is recommended to ensure the safety of the sports ground before exercise: keep the ground dry, clean, not easy to slip, no debris; Comfortable clothing and non-slip exercise are recommended.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    The experimental group

    The experimental group performed aerobic resistance exercise during pregnancy every day.

    Behavioral: aerobic and resistance exercise

  • No intervention
    The control group

    The control group was given traditional nursing.

Interventions

  • Behavioralaerobic and resistance exercise

    The experimental group performed aerobic resistance exercise during pregnancy every day.

06

What researchers measure

Primary outcomes

  1. Blood glucose

    Fasting blood glucose in pregnant women with GDM

    Time frame: Collect blood samples and monitor fasting blood glucose in pregnant womendaily until delivery, it can be monitored for up to 10 months.

  2. 2 hours blood glucose

    2 hours postprandial blood glucose in pregnant women with GDM

    Time frame: Collect blood samples and monitor 2 hours postprandial blood glucosedaily until delivery, it can be monitored for up to 10 months.

  3. HbA1c

    HbA1c in pregnant women with GDM

    Time frame: Collect blood samples and monitor monthly until delivery, it can be monitored for up to 10 months.

  4. Maternal weight gain

    Maternal Weight Gain during Pregnancy

    Time frame: Monitor weight daily until delivery by weighing scale, it can be monitored for up to 10 months.

  5. Pulse

    The pulse of pregnant women in the experimental group during exercise

    Time frame: Monitor the pulse of pregnant women in the experimental group during exercise until delivery, it can be monitored for up to 10 months.

07

Study locations

1 of 1 sites recruiting
  • department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang 325027, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05901402
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University
Responsible party
Sponsor
First posted
Jun 13, 2023
Start date
Mar 1, 2023
Primary completion
May 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Feb 6, 2024

Study contacts

Xiaofen Zhang
Contact
7850758@qq.com
+8613968824305

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion